Ocular Therapeutix, Inc

Ownership Transactions Reported by 20 Insiders

Symbol
OCUL on Nasdaq
Industry
Pharmaceutical Preparations
Location
15 Crosby Drive, Bedford, MA

Insiders trading volume in the past year

Ocular Therapeutix, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Summer Road Llc 10%+ Owner $64.6M +$7M +12.2% Feb 26, 2024
Pravin Dugel Executive Chairman, President and CEO, Director $7.13M -$500K -6.55% Nov 25, 2024
Antony C. Mattessich President and CEO, Director $2.89M +$4.69K +0.16% Feb 3, 2024
Jeffrey S. Heier Chief Scientific Officer $2.42M -$26.6K -1.08% Nov 25, 2024
Peter Kaiser Chief Development Officer $1.92M -$26.1K -1.34% Nov 25, 2024
Donald Notman Chief Operating Officer and Chief Financial Officer $1.89M -$1.65K -0.09% Aug 29, 2024
Sanjay Nayak Chief Strategy Officer $1.57M -$46.1K -2.86% Nov 25, 2024
Michael H. Goldstein President, Ophthalmology & CMO $1.54M Feb 3, 2022
Richard L. Md Lindstrom Director $950K Feb 27, 2024
Todd Anderman Chief Legal Officer $890K Oct 7, 2024
Nadia Waheed Chief Medical Officer $827K Jun 1, 2024
Philip C. Strassburger General Counsel $785K -$4.51K -0.57% Feb 3, 2024
Rabia Gurses Ozden Chief Medical Officer $744K -$7.59K -1.01% Feb 3, 2024
Christopher G. White Chief Business Officer $601K +$3.25K +0.54% Feb 3, 2024
Charles M. Warden Director $423K Jul 24, 2024
Leslie J. Williams Director $219K Jul 24, 2024
Adrienne L. Graves Director $210K Jul 24, 2024
Merilee Raines Director $192K Jul 24, 2024
Seung Suh Hong Director $192K Jul 24, 2024
Bruce Peacock Director Jun 18, 2021

Recent Insider Transactions by Companies or Individuals for Ocular Therapeutix, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.